Generate:Biomedicines CEO Mike Nally explains how Generate is a case example of the power of polyintelligence as it brings together human, machine, and nature’s intelligence to pioneer generative AI technologies in biology. Catch the full CEO Chat for more on Generate’s expanding pipeline of programs and partnerships, including with Amgen, Novartis, and others. More from Flagship @ JPM2025 here.
Related Companies
- Generate:Biomedicines Founded: 2018